Patent Medicine Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Medicine Type (Solid Drug Products, Semi-Solid Drug Products, Liquid Drug Products, Gas/Aerosols Drug Products, Others); Indication (Cardiovascular Disease, Respiratory Disease, Immunological Disease, Blood Disease, Gastrointestinal Disease, Ophthalmic Disease, Orthopedic Disease, Neurodegenerative Disease, Others)
A patent medicine is a proprietary medicine made and marketed under a patent and is owned by an individual company. Patent medicine means that only the pharmaceutical company that holds the patent is allowed to manufacture and make profit out of it. In most cases, drug patent is awarded for 20 years to pharmaceutical companies.
The patent medicine market is driving due to increasing prevalence of diseases worldwide, and increasing research and development activities globally. However, high cost of patent medicine as compared to generic medicine is expected to hamper the growth of the global patent medicine market. Moreover, increasing pipeline of patented drugs is anticipated to drive demand the growth of the market.
The "Patent Medicine Market Analysis to 2027" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of Patent Medicine market with detailed market segmentation by medicine type, and indication. The Patent Medicine market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Patent Medicine market and offers key trends and opportunities in the market.
The Patent Medicine market is segmented based on medicine type, and indication. Based on medicine type, the market is segmented into solid drug products, semi-solid drug products, liquid drug products, gas/aerosols drug products, others. Based on indication, the market is segmented into cardiovascular disease, respiratory disease, immunological disease, blood disease, gastrointestinal disease, ophthalmic disease, orthopedic disease, neurodegenerative disease, and others.
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Patent Medicine market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Patent Medicine market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting Patent Medicine market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely, North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social, and technological factors effecting the Patent Medicine market in these regions.
Get more information on this report :
The report covers key developments in the Patent Medicine market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Patent Medicine market are anticipated to have lucrative growth opportunities in the future with the rising demand for Patent Medicine market in the global market. Below mentioned is the list of few companies engaged in the Patent Medicine market.
The report also includes the profiles of key players in Patent Medicine market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
Otsuka Pharmaceutical Co., Ltd.
Merck & Co., Inc.
Roche Holding AG
Bristol-Myers Squibb Company
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
Get more information on this report :
TABLE OF CONTENTS
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Patent Medicine Market - By Medicine Type
1.3.2 Patent Medicine Market - By Indication
1.3.3 Patent Medicine Market - By Region
188.8.131.52 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. PATENT MEDICINE MARKET LANDSCAPE
4.2. PEST ANALYSIS
4.3. EXPERT OPINIONS
5. PATENT MEDICINE MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. PATENT MEDICINE MARKET - GLOBAL MARKET ANALYSIS
6.1. PATENT MEDICINE - GLOBAL MARKET OVERVIEW
6.2. PATENT MEDICINE - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. PATENT MEDICINE MARKET - REVENUE AND FORECASTS TO 2027 - MEDICINE TYPE
7.2. MEDICINE TYPE MARKET FORECASTS AND ANALYSIS
7.3. SOLID DRUG PRODUCTS
7.3.2. Solid Drug Products Market Forecast and Analysis
7.4. SEMI-SOLID DRUG PRODUCTS
7.4.2. Semi-Solid Drug Products Market Forecast and Analysis
7.5. LIQUID DRUG PRODUCTS
7.5.2. Liquid Drug Products Market Forecast and Analysis
7.6. GAS/AEROSOLS DRUG PRODUCTS
7.6.2. Gas/Aerosols Drug Products Market Forecast and Analysis
7.7.2. Others Market Forecast and Analysis
8. PATENT MEDICINE MARKET - REVENUE AND FORECASTS TO 2027 - INDICATION
8.2. INDICATION MARKET FORECASTS AND ANALYSIS
8.3. CARDIOVASCULAR DISEASE
8.3.2. Cardiovascular Disease Market Forecast and Analysis
8.4. RESPIRATORY DISEASE
8.4.2. Respiratory Disease Market Forecast and Analysis
8.5. IMMUNOLOGICAL DISEASE
8.5.2. Immunological Disease Market Forecast and Analysis
8.6. BLOOD DISEASE
8.6.2. Blood Disease Market Forecast and Analysis
8.7. GASTROINTESTINAL DISEASE
8.7.2. Gastrointestinal Disease Market Forecast and Analysis
8.8. OPHTHALMIC DISEASE
8.8.2. Ophthalmic Disease Market Forecast and Analysis
8.9. ORTHOPEDIC DISEASE
8.9.2. Orthopedic Disease Market Forecast and Analysis
8.10. NEURODEGENERATIVE DISEASE
8.10.2. Neurodegenerative Disease Market Forecast and Analysis
8.11.2. Others Market Forecast and Analysis
9. PATENT MEDICINE MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL PATENT MEDICINE MARKET
10.1 North America
10.4 Middle East and Africa
10.5 South and Central America
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. PATENT MEDICINE MARKET, KEY COMPANY PROFILES
12.1. PFIZER INC.
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. OTSUKA PHARMACEUTICAL CO., LTD.
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. GLAXOSMITHKLINE PLC
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. NOVARTIS AG
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. MERCK AND CO., INC.
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. ROCHE HOLDING AG
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. AMGEN INC.
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. ABBVIE INC.
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. BRISTOL-MYERS SQUIBB COMPANY
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies
1. Pfizer Inc.
2. Otsuka Pharmaceutical Co., Ltd.
3. GlaxoSmithKline plc
4. Novartis AG
5. Merck & Co., Inc.
6. Roche Holding AG
7. Amgen Inc.
8. AbbVie Inc.
10. Bristol-Myers Squibb Company